Johnson & Johnson (NYSE:JNJ) is not only a Dividend Aristocrat, it is also a Dividend King. The 51 Dividend Aristocrats are a group of companies in the S&P 500 Index, with 25+ consecutive years of dividend increases. The Dividend Kings are an even more exclusive group of stocks, with 50+ years of consecutive dividend increases. J&J stock is one of only 22 Dividend Kings. Johnson & Johnson has been in operation for 130 years, and has raised its dividend for 55 years in a row
J&J’s pharmaceutical segment is its strongest area of growth. This segment has generated much higher growth rates than medical devices or consumer products, in recent periods. For example, J&J had adjusted earnings-per-share of $6.73 in 2016, which represented 8% growth from the previous year. Organic revenue increased 7% for 2016. By 2021, J&J expects to file 10 new products, each with annual sales potential of $1 billion or more. It also sees the potential for 40 line extensions to existing products by then. Of these 40 extensions, 10 of which have the potential for more than $500 million in annual revenue.
Source: InvestorPlace
Related Articles:
- 4 Dividend Stocks Delivering The Secret To Successful Investing
- The Magnificent Marvelous Money Machine
- 5 Five-Star Dividend Stocks
- My Top 3 Investing Mistakes
- 6 Stocks Currently Trading Below their Fair Value
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Many companies have been suspending their dividends during the COVID-19 crisis, and in many cases it is understandable. In times of economic...
-
While near-term fluctuations in the stock market can be unpredictable, dividends are one of the few reliable sources of market returns. Stoc...
-
“Research shows that dividend cuts are associated with significant share price declines on announcement,” Cornell University Professor of Fi...
-
AbbVie (NASDAQ:ABBV) is in the midst of a transition. AbbVie began life about a decade ago when it was spun off from health care and medical...
-
With interest rates at historic lows and bond-yields heading down quickly, the payouts from dividend stocks are becoming more and more appea...
-
3M Company (NYSE:MMM) is growing its FCF very well, and as a result, MMM stock is likely to move up at least 44% over the next or so. Right ...
-
Warren Buffett has said the best time to sell is never, and though he often doesn't follow his own rules -- as the recent sale of all th...
-
Dividend investing is a great way for investors to earn reliable income. Dividend stocks tend to have stable, cash-generating business model...
-
We’ve pulled up the details on some of Oppenheimer's recommendations. These are stocks with a specific set of clear attributes, that fre...
-
Looking for survivors in the high-yield midstream space? This general partner just dropped down $48M in trucking assets. Management is guidi...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.